ValueAct Buys 3M Valeant Pharma (VRX) Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Pinterest CFO resigns, interim replacement named
Valeant Pharma (VRX) Director De Schutter Buys 10K Shares
March 16, 2017 5:17 PM EDTValeant Pharma (NYSE: VRX) Director, Richard De Schutter, bought 10,000 shares on 03/15 at $10.80
... MoreValeant Pharma (VRX) CFO Buys 24K Shares
March 16, 2017 5:09 PM EDTValeant Pharma (NYSE: VRX) CFO Paul Herendeen disclosed buying 24,000 shares on 03/14 at $10.72, bringing his stake to 174,000 shares.
The disclosure from Herendeen follows the 3 million share purchase from large and noted investor group ValueAct capital.
FORM... More
